These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 4596743)

  • 1. Clinical significance of in vitro synergism between antibiotics in gram-negative infections.
    Klastersky J; Cappel R; Daneau D
    Antimicrob Agents Chemother; 1972 Dec; 2(6):470-5. PubMed ID: 4596743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gram-negative infections in cancer. Study of empiric therapy comparing carbenicillin-cephalothin with and without gentamicin.
    Klastersky J; Henri A; Hensgens C; Daneau D
    JAMA; 1974 Jan; 227(1):45-8. PubMed ID: 4202683
    [No Abstract]   [Full Text] [Related]  

  • 3. Combinations of antibiotics for therapy of severe infections in cancer patients.
    Klastersky J
    Eur J Cancer (1965); 1979; 15 Suppl():3-13. PubMed ID: 232443
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-lactam antibiotics alone or in combination with gentamicin for therapy of gram-negative bacillary infections in neutropenic patients.
    Bodey GP; Feld R; Burgess MA
    Am J Med Sci; 1976; 271(2):179-86. PubMed ID: 773180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of the results of antibiotic synergy and susceptibility testing in vitro with results in experimental mouse infections.
    Isenberg HD; Sampson-Scherer J; Cleeland R; Titsworth E; Beskid G; Christenson JG; DeLorenzo WF; Unowsky J
    Crit Rev Microbiol; 1982; 10(1):1-76. PubMed ID: 6756787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy between ticarcillin and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae in vitro and in vivo.
    Comber KR; Basker MJ; Osborne CD; Sutherland R
    Antimicrob Agents Chemother; 1977 Jun; 11(6):956-64. PubMed ID: 406837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo synergy between 6 beta-amidinopenicillanic acid derivatives and other antibiotics.
    Grunberg E; Cleeland R; Beskid G; DeLorenzo WF
    Antimicrob Agents Chemother; 1976 Apr; 9(4):589-94. PubMed ID: 178275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of combinations of amikacin with penicillin G and amikacin with carbenicillin in gram-negative septicemia: double-blind clinical trial.
    Klastersky J; Hensgens C; Meunier-Carpentier F
    J Infect Dis; 1976 Nov; 134 SUPPL():S433-40. PubMed ID: 792359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of infections caused by gram-negative bacilli: the role of antimicrobial combinations.
    Allan JD; Moellering RC
    Rev Infect Dis; 1985; 7 Suppl 4():S559-71. PubMed ID: 3909313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of synergistic combinations of antibiotics in patients with haematological diseases.
    Klastersky J
    Clin Haematol; 1976 Jun; 5(2):361-77. PubMed ID: 780029
    [No Abstract]   [Full Text] [Related]  

  • 11. Synergistic combinations of antibiotics in gram-negative bacillary infections.
    Klastersky J; Zinner SH
    Rev Infect Dis; 1982; 4(2):294-301. PubMed ID: 7051232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced antibacterial effect of antibiotics in combination with silver nanoparticles against animal pathogens.
    Smekalova M; Aragon V; Panacek A; Prucek R; Zboril R; Kvitek L
    Vet J; 2016 Mar; 209():174-9. PubMed ID: 26832810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of antimicrobial synergism for the outcome of gram negative sepsis.
    Klastersky J; Meunier-Carpentier F; Prevost JM
    Am J Med Sci; 1977; 273(2):157-67. PubMed ID: 324279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic combinations of gram-negative infections in patients with cancer.
    Klastersky J; Daneau D; Henri A; Cappel R; Hensgens C
    Eur J Cancer (1965); 1973 Jun; 9(6):407-15. PubMed ID: 4372048
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuous infusion tobramycin combined with carbenicillin for infections in cancer patients.
    Issell BF; Keating MJ; Valdivieso M; Bodey GP
    Am J Med Sci; 1979; 277(3):311-8. PubMed ID: 256433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
    Granowetter L; Wells H; Lange BJ
    Pediatr Infect Dis J; 1988 Mar; 7(3):165-70. PubMed ID: 3282214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by gram-negative rods.
    Klastersky J; Cappel R; Daneau D
    Cancer; 1973 Feb; 31(2):331-6. PubMed ID: 4569296
    [No Abstract]   [Full Text] [Related]  

  • 18. Piperacillin and gentamicin v carbenicillin and gentamicin for treatment of serious gram-negative infections.
    Kohler RB; Foerster LA; Wheat LJ; Williams JM; Reynolds J; Norton J
    Arch Intern Med; 1982 Jul; 142(7):1335-7. PubMed ID: 6212035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of gentamicin in severe gram-negative infections].
    Klastersky J; Cappel R
    Schweiz Rundsch Med Prax; 1973 Apr; 62(17):537-42. PubMed ID: 4574009
    [No Abstract]   [Full Text] [Related]  

  • 20. Bacteriostatic and bactericidal activities of beta-lactam antibiotics enhanced by the addition of low concentrations of gentamicin.
    Masuda G; Nakamura K; Yajima T; Saku K
    Antimicrob Agents Chemother; 1980 Mar; 17(3):334-6. PubMed ID: 6775591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.